Company intelligence / Profile preview
Sachi Bio
United Statessachibio.com ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Four drug candidates in preclinical development for Parkinson's, inflammatory bowel disease, an undisclosed neuroimmune disease, and one candidate designed to counteract radiation exposure. In a NASA space medicine project, identified 17 target genes in 6 weeks and demonstrated ability to turn proteins on and off as desired in mice without needing a lipid to bind and deliver the treatment and without creating toxic concentrations in the liver or other key organs.
- Therapeutic areas
- GastroenterologyNeurologyOther
- Modalities
- RNA therapeuticsnucleic acid molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
NASA (space medicine project)SpaceX (CRS-31 mission)
Beyond the preview
Go deeper on Sachi Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sachi Bio.